Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Biotechnology

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Ted Ohashi-Chris Bunka Interview

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Jul 11, 2022 2:36pm

79 Views

Post# 34815812

RE:Ted Ohashi-Chris Bunka Interview

wow OHASHI!!!

I suspect this will mean the smae forLEXX as his other pciks

Like KHRN and TGIF

lke.. down 90+% since he liked them

But I wonder....wtf likes OHASh????? Unless you short

He is as 'good' at picking as agstockPUMPER

which means...NOT GOOD AT ALL

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks